Aptevo Therapeutics (APVO) Tops Q1 EPS by 161c

Aptevo Therapeutics (NASDAQ: APVO) reported Q1 EPS of $0.26, $1.61 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group